Structural requirements of lipid A for endotoxicity and other biological activities.
about
Quantification of ergosterol and 3-hydroxy fatty acids in settled house dust by gas chromatography-mass spectrometry: comparison with fungal culture and determination of endotoxin by a Limulus amebocyte lysate assayStructural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2Airborne environmental endotoxin: a cross-validation of sampling and analysis techniquesMembrane Insertion for the Detection of Lipopolysaccharides: Exploring the Dynamics of Amphiphile-in-Lipid AssaysNovel variation of lipid A structures in strains of different Yersinia species.Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action.Ordering of lipid A-monophosphate clusters in aqueous solutions.Observations of liquidlike order of charged rodlike lipid A diphosphate assemblies at pH 8.5.Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activityN-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes.Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response.Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?Structural characterization of the lipids A of three Bordetella bronchiseptica strains: variability of fatty acid substitution.Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analoguesMolecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharidesStructural characterization of the lipid A of Bordetella pertussis 1414 endotoxin.Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.Comparison of lipids A of several Salmonella and Escherichia strains by 252Cf plasma desorption mass spectrometryLipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure.Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines.Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.Rhodopseudomonas sphaeroides lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid AEnzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS.N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.Cardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine.Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity.De novo design of potent antimicrobial peptidesKey structures of bacterial peptidoglycan and lipopolysaccharide triggering the innate immune system of higher animals: chemical synthesis and functional studiesLipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties.Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines.Reviewing and identifying amino acids of human, murine, canine and equine TLR4 / MD-2 receptor complexes conferring endotoxic innate immunity activation by LPS/lipid A, or antagonistic effects by Eritoran, in contrast to species-dependent modulationBiosynthetically engineered lipopolysaccharide as vaccine adjuvant.Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner.Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23.A novel component different from endotoxin extracted from Prevotella intermedia ATCC 25611 activates lymphoid cells from C3H/HeJ mice and gingival fibroblasts from humans.Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis.Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses.
P2860
Q23923044-8DC77739-03F2-427C-A7CA-DB7C656A9E00Q27678726-C85741A9-F1DC-4E18-8428-D6E1CF0B21FDQ28396775-069F9E9A-996D-459F-9BE8-2CCB317E1E7CQ28552464-7FA0C251-2BF5-417A-939F-B0BF83E1C427Q30830535-7259E029-B03F-4E25-8CEC-4657B0855AEEQ31473556-623FD6B1-4D14-4283-AA5D-0A31B1A3F945Q33299925-DED8360D-BB9D-4B4A-B1ED-5EB164BE4120Q33320172-984A564A-32CB-4E8E-AB4A-A473BF0CFA9BQ33596606-2303047D-B746-482F-A50D-8438177C91DBQ33726426-5A35E474-E140-4983-A23E-A06912EC7C84Q33768763-739076CA-FE85-4D5D-962E-01D48895807DQ33946526-0B9D97B0-BE0B-43D8-868A-0FCE100B2F77Q34001444-1DC76D0F-5C14-442B-A33D-4615A7A17FECQ34001964-AB397F0F-0BF2-48BB-B369-3D4008A6151CQ35173769-291ED218-6524-4BF4-B306-364DD915D7F6Q35624097-992EEF21-461D-4162-A0F8-C6E27FF77FF9Q35737359-1C918D20-1440-4979-933D-315C7B35B532Q35781825-49013D79-BD1D-43FE-9910-47D6D1D09B1CQ35968686-356206AB-0EC3-4424-9DEE-1582A2236936Q35987326-D2CB8A17-5042-40D6-948A-ABA32B94CC1BQ36100061-1282121E-B3C6-4D89-94BA-54DB9673D1C9Q36171584-DFEA2C12-BA2B-467D-A599-6DA163A2CBC1Q36942941-51376A46-4E8F-471E-BE56-47A0EE2EF727Q36947204-DFD41036-F331-4339-A273-72D294A431EEQ36952199-E7B07E0B-459A-4DF3-A147-B03AF1F9818FQ36964293-2CB9AF26-2E34-4CAA-A390-D10165735B1CQ37116328-BBB172AA-8EBB-4AB1-9FBD-FDED07FB6BCDQ37122290-ABC3D003-3674-476D-91C5-1712C8686819Q37256450-011A20FA-25F4-4C07-9CB7-EEC476D54027Q37489546-843CDE72-A819-4092-8744-BFE32469BC64Q37739736-F3A29397-C98A-4F1E-ACD7-A4A0377D8298Q37804408-9C06D42A-2E6A-4448-96D2-59EE18A894D2Q38032881-E5AB27D9-A88D-4CE0-949E-3ABBF264F6D0Q38201040-BCB6412D-7F2C-4AC0-B9C0-B11AC86DA14BQ38386726-5E966DAA-03F1-40C9-930D-03A55FA2CD0BQ39510350-21597ED8-7136-46E1-8D23-6A033AF3E952Q39822193-DF346F18-13A8-4534-906C-B04974FD99EAQ39831390-71BE27E0-6836-4DE2-A6CE-7F2F7E96968FQ40090049-C35E0AF0-2179-4A11-BAB5-D0FB19B2E750Q40574382-FEFB40DC-CC64-4ECA-AA84-96AB4A143B04
P2860
Structural requirements of lipid A for endotoxicity and other biological activities.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Structural requirements of lipid A for endotoxicity and other biological activities.
@en
type
label
Structural requirements of lipid A for endotoxicity and other biological activities.
@en
prefLabel
Structural requirements of lipid A for endotoxicity and other biological activities.
@en
P2860
P1476
Structural requirements of lipid A for endotoxicity and other biological activities.
@en
P2093
P2860
P304
P356
10.3109/10408418909104475
P407
P577
1989-01-01T00:00:00Z